JPRN-UMIN000006840已完成未知
Research of gemcitabine sensitivity in pancreatic cancer. - Research of gemcitabine sensitivity in pancreatic cancer.
Gifu University Dept. of Gastroenterology0 个研究点目标入组 100 人开始时间: 2011年12月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Advanced pancreatic cancer could not be diagnosed by EUS-FNA.
研究者
相似试验
已完成
2 期
A phase II study of gemcitabine in pancreatic endocrine tumorpancreatic endocrine tumorJPRN-UMIN000001487ational Cancer Center Hospital18
已完成
2 期
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic CancerPancreatic CancerNCT00733850KangLaiTe USA85
招募中
不适用
The influence of pancreatic function on the pharmacokinetics of ivacaftor in patients with cystic fibrosismucoviscidosisCystic FibrosisNL-OMON51011HagaZiekenhuis20
Unknown
1 期
Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal CytologyPancreatic AdenocarcinomaNCT03703089Benaroya Research Institute21
招募中
不适用
Prospective study for the effects of pancreatic enzyme replacement therapy on quality of life and nutritional assessment after pancreas resectioDiseases of the digestive systemKCT0000010Seoul National University232